VEGF is an important regulator of physiological and pathological angiogenesis, which can promote endothelial cell proliferation and tumor growth, and the level of VEGF is associated with clinical outcome in hematologic malignancies including AML [13]. The gene discussed is VEGFA; the disease is acute myeloid leukemia.